Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial

Breast Cancer Research and Treatment

Volumn 66, Issue 3, 2001, Pages 239-248

  Van Poznak, C ^a   Seidman, A D ^a   Reidenberg, M M ^b   Moasser, M M ^a   Sklarin, N ^a   Van Zee, K ^a   Borgen, P ^a   Gollub, M ^a   Bacotti, D ^a   Yao, T J ^a   Bloch, R ^a   Ligueros, M ^a   Sonenberg, M ^a   Norton, L ^a   Hudis, C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cyclin D1; Gossypol; Novel chemotherapeutics; Retinoblastoma gene product

Indexed keywords

ANTHRACYCLINE; CYCLIN D1; GOSSYPOL; TAXANE DERIVATIVE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; CARCINOMA CELL; CELL CYCLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; SKIN TOXICITY;

ADMINISTRATION, ORAL; ADULT; AGED; BREAST NEOPLASMS; CELL CYCLE; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FATIGUE; FEMALE; GOSSYPOL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NAUSEA; RETINOBLASTOMA PROTEIN; TASTE DISORDERS; TREATMENT OUTCOME;

EID: 0034922672     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010686204736     Document Type: Article

References (29)

1. Biochemical correlates of the anti-tumor and anti-mitochondrial properties of gossypol enantiomers
2. Action of gossypol and rhodamine 123 on wild type and multidrug resistant MCF-7 human breast cancer cell 31P nuclear magnetic resonance and toxicity studies
3. Differential cytotoxic effect of gossypol on human melanoma colon carcinoma and other tissue culture cell lines
4. Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro
5. Inhibition of DNA polymerase alpha by gossypol
6. Modulation of 4′-(9-acrinidylamino) methanesulfon-m-anisided-induced topoisomerase II medicated DNA cleavage by gossypol
7. Antitumor effects of gossypol on murine tumors
8. Gossypol inhibits Ehrlich ascites tumor cell proliferation
9. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors
10. Structural rearrangement of the retinoblastoma gene in human breast carcinoma
11. Rb and the cell cycle: Entrance or exit?
12. Cyclin D1 protein oscillates and is essential for cell cycle progression in human turnout cell lines
13. Expression and amplification of cyclin genes in human breast cancer
14. Redundant cyclin overexpression and gene amplification in breast cancer cells
15. Cyclin D1 in breast cancer
16. Gossypol inhibition of mitosis, cyclin D1, and Rb protein in human mammary cancer cells and cyclin D1 transfected human fibrosarcoma cells
17. Studies of gossypol in the treatment of cancer
18. A preliminary clinical study of gossypol in advanced human cancer
19. Oral gossypol in the treatment of metastatic adrenal cancer
20. Gossypol treatment of recurrent adult malignant gliomas
21. The determination of the number of patients required in a preliminary and follow up trial of a new chemotherapeutic agent
22. Antiproliferative activity of gossypol and gossypolone on human breast cancer cells
23. Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell lines
24. Cyclin D1 and breast cancer
25. Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in turnout cell lines
26. Anti-proliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines
27. The ( - )-enantiomer of gossypol inhibits proliferation of stromal cells derived from human breast adipose tissues by enhancing transforming growth factor Beta 1 production
28. Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies
29. Inhibition of Human Class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amount of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol. Advances in Experimental medicine and biology